📰 Pharma Services News
Page 4 - Pharma Services News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Services. Real-time updates on events, politics, business and more.
February 9, 2024
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The
February 6, 2024
Thermo Fisher Scientific Inc. (NYSE:TMO) Q4 2023 Earnings Call Transcript January 31, 2024 Operator: Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2023 Fourth Quarter Conference Call. My name is Bailey and I’ll be your moderator for today’s call. All lines will be muted during the presentation portion with an opportunity […]
February 6, 2024
/PRNewswire/ -- The "Global Lipid Nanoparticle Manufacturing Market 2023-2035: Services and Technologies - Distribution by Type of Lipid Nanoparticle, Type of...
February 6, 2024
Operator: Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2023 Fourth Quarter Conference Call. My name is Bailey and Ill be your moderator for todays call.
February 1, 2024
Illinois Municipal Retirement Fund acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 78,076 shares of the medical research company’s stock, valued at approximately $960,000. Illinois Municipal Retirement Fund owned approximately 0.06% […]
January 25, 2024
/PRNewswire/ -- The "Pharma Clinical Trial Services Market Report 2024-2034" report has been added to ResearchAndMarkets.coms offering. Pharma Clinical Trial...
January 24, 2024
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The
January 22, 2024
Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agency (AIFA) allowing the company to manufacture RNA-based products at its Monza, Italy site. The approval and associated certification support increased accessibility ...
January 19, 2024
Think Research Announces Agreement for Subsequent Advance Under Existing ...
January 18, 2024
Perkins Capital Management Inc. cut its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 1.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 193,950 shares of the medical research company’s stock after selling 2,550 shares during […]